Related Experiment Video
Updated: Feb 25, 2026
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
3.6K
Novel biomarkers for systemic lupus erythematosus
Jinrong Zeng1, Haijing Wu1, Ming Zhao1
1Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Biomarkers in Medicine
|August 4, 2017
Summary
Systemic lupus erythematosus (SLE) treatment needs personalization due to disease complexity. This review explores novel biomarkers for individualized SLE therapy, assessing their clinical potential and correlation with disease activity.
Area of Science:
- Immunology
- Rheumatology
- Pharmacology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease with extreme patient heterogeneity.
- Limited success in developing new SLE therapies over 50 years, with only Belimumab approved.
- Current understanding of SLE pathogenesis and patient variability hinders drug development.
Purpose of the Study:
- To comprehensively review novel biomarkers for SLE.
- To discuss the current status of these biomarkers in preclinical and clinical settings.
- To evaluate biomarker potential for guiding individualized SLE treatment strategies.
Main Methods:
- Literature review of recent studies on SLE biomarkers.
- Analysis of biomarker sensitivity to treatments.
- Assessment of biomarker correlation with SLE disease activity.
Main Results:
- Identified several novel potential biomarkers for SLE.
- Summarized current preclinical and clinical data for these biomarkers.
- Evaluated the relationship between biomarkers, treatment response, and disease activity.
Conclusions:
- Biomarkers show significant promise for enabling individualized SLE treatment.
- Further research is needed to validate biomarkers for clinical application.
- Biomarker-guided therapy could overcome challenges in SLE drug development and patient management.
